I agree with you muzzarati. A Singapore company revealed >5% ownership of INP and it went up more than 12% on the news.
Phase 2 trials in the US for a more effective common cold treatment got Biota just above the ASX200 increase.
Common cold is incredibly more significant than some dude in Singapore deciding he liked a piece of INP.
- Forums
- ASX - By Stock
- BTA
- hrv trial
hrv trial, page-4
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online